Alzheimer’s Disease: Efficacy of Mono- and Combination Therapy. A Systematic Review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alzheimer’s Disease: Efficacy of Mono- and Combination Therapy. A Systematic Review
Authors
Keywords
-
Journal
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
Volume -, Issue -, Pages 089198872110447
Publisher
SAGE Publications
Online
2021-09-03
DOI
10.1177/08919887211044746
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies
- (2020) Sara Linse et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The neuropathological diagnosis of Alzheimer’s disease
- (2019) Michael A. DeTure et al. Molecular Neurodegeneration
- The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
- (2018) Harald Hampel et al. BRAIN
- Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease
- (2018) Alireza Atri et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diffusion Tensor Imaging of the Hippocampus in MCI and Early Alzheimer's Disease
- (2018) Andreas Fellgiebel et al. JOURNAL OF ALZHEIMERS DISEASE
- Disease Tracking Markers for Alzheimer's Disease at the Prodromal (MCI) Stage
- (2018) Valeria Drago et al. JOURNAL OF ALZHEIMERS DISEASE
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
- (2017) Susanne Ostrowitzki et al. Alzheimers Research & Therapy
- Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer’s disease
- (2017) Enrica Cavedo et al. Scientific Reports
- Cholinesterase Inhibitor Therapy in Alzheimer’s Disease: The Limits and Tolerability of Irreversible CNS-Selective Acetylcholinesterase Inhibition in Primates
- (2016) Donald E. Moss et al. JOURNAL OF ALZHEIMERS DISEASE
- Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease
- (2015) Bruno Dubois et al. Alzheimers & Dementia
- The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis
- (2015) Hisanori Kobayashi et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Alzheimer's disease
- (2015) Colin L. Masters et al. Nature Reviews Disease Primers
- The effects of combine treatment of memantine and donepezil on Alzheimer's Disease patients and its relationship with cerebral blood flow in the prefrontal area
- (2014) Tomoko Araki et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors
- (2013) George T. Grossberg et al. CNS DRUGS
- Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease
- (2013) Chris G. Parsons et al. NEUROTOXICITY RESEARCH
- Efficacy and Safety of Donepezil 23 mg versus Donepezil 10 mg for Moderate-to-Severe Alzheimers Disease: A Subgroup Analysis in Patients Already Taking or Not Taking Concomitant Memantine
- (2012) Rachelle S. Doody et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI
- (2012) Oliver Peters et al. Journal of Nutrition Health & Aging
- Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
- (2012) Robert Howard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cognitive reserve, cortical plasticity and resistance to Alzheimer's disease
- (2012) Margaret M Esiri et al. Alzheimers Research & Therapy
- Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer’s disease
- (2011) Michael W. Weiner et al. Alzheimers & Dementia
- ST101 induces a novel 17kDa APP cleavage that precludes Aβ generation in vivo
- (2011) Kim N. Green et al. ANNALS OF NEUROLOGY
- Evidence for Ordering of Alzheimer Disease Biomarkers
- (2011) Clifford R. Jack ARCHIVES OF NEUROLOGY
- Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study
- (2011) Seong Hye Choi et al. CURRENT MEDICAL RESEARCH AND OPINION
- Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study
- (2010) Martin R. Farlow et al. CLINICAL THERAPEUTICS
- Treatment of Alzheimer’s Disease with a Cholinesterase Inhibitor Combined with Antioxidants
- (2010) Umberto Cornelli Neurodegenerative Diseases
- Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe
- (2010) H. H. Feldman et al. NEUROLOGY
- Ginkgo bilobaextract EGb 761®, donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: A randomised, double-blind, exploratory trial
- (2009) S. Yancheva et al. AGING & MENTAL HEALTH
- Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2008) Anton Porsteinsson et al. Current Alzheimer Research
- Safety and efficacy of galantamine in subjects with mild cognitive impairment
- (2008) B. Winblad et al. NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started